Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

GNSC

Genaissance (GNSC)

Genaissance Pharmaceuticals (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:GNSC
DateTimeSourceHeadlineSymbolCompany
10/03/20058:00AMPR Newswire (US)Genaissance Enters into HAP(TM) Technology License Agreement with SankyoNASDAQ:GNSCGenaissance Pharmaceuticals (MM)
09/21/20058:00AMPR Newswire (US)Genaissance Enters Pharmacogenomic Collaboration with OtsukaNASDAQ:GNSCGenaissance Pharmaceuticals (MM)
09/12/20058:00AMPR Newswire (US)Genaissance Pharmaceuticals and Ipsogen Announce Cancer Biomarker Research AgreementsNASDAQ:GNSCGenaissance Pharmaceuticals (MM)
08/23/20058:30AMPR Newswire (US)Genaissance Will Provide Genotyping Services for Cyprus Scrapie ContractNASDAQ:GNSCGenaissance Pharmaceuticals (MM)
08/11/20058:30AMPR Newswire (US)Genaissance Will Provide Exclusive Genotyping Services for Greek Scrapie ContractNASDAQ:GNSCGenaissance Pharmaceuticals (MM)
07/18/20058:30AMPR Newswire (US)Genaissance Pharmaceuticals Enters into HAP(TM) Technology License Agreement with OrganonNASDAQ:GNSCGenaissance Pharmaceuticals (MM)
06/21/20058:15AMPR Newswire (US)Clinical Data to Acquire Genaissance PharmaceuticalsNASDAQ:GNSCGenaissance Pharmaceuticals (MM)
06/21/20057:15AMBusiness WireClinical Data to Acquire Genaissance Pharmaceuticals; Combined Company to Deliver Industry-Defining TheranosticsNASDAQ:GNSCGenaissance Pharmaceuticals (MM)
06/07/20058:30AMPR Newswire (US)Genaissance to Provide Pharmacogenetic Support to INC Research, Its First CRO PartnerNASDAQ:GNSCGenaissance Pharmaceuticals (MM)
05/03/20058:30AMPR Newswire (US)Genaissance Reports First Quarter 2005 ResultsNASDAQ:GNSCGenaissance Pharmaceuticals (MM)
04/28/20054:23PMPR Newswire (US)Genaissance Pharmaceuticals Comments on Stock ActivityNASDAQ:GNSCGenaissance Pharmaceuticals (MM)
04/27/200511:00AMPR Newswire (US)Genaissance Pharmaceuticals to Present at Rodman & Renshaw Techvest 2nd Annual Global Healthcare ConferenceNASDAQ:GNSCGenaissance Pharmaceuticals (MM)
04/26/200511:00AMPR Newswire (US)Genaissance Pharmaceuticals, Inc. Invites You to Participate in its First Quarter 2005 Conference CallNASDAQ:GNSCGenaissance Pharmaceuticals (MM)
04/22/20058:31AMPR Newswire (US)Genaissance Pharmaceuticals Obtains $4.5 Million Secured Debt FinancingNASDAQ:GNSCGenaissance Pharmaceuticals (MM)
04/22/20058:30AMPR Newswire (US)Genaissance Pharmaceuticals Obtains $4.5 Million Secured Debt FinancingNASDAQ:GNSCGenaissance Pharmaceuticals (MM)
04/06/20058:32AMPR Newswire (US)Genaissance and ParAllele BioScience Sign License and Co-Marketing AgreementNASDAQ:GNSCGenaissance Pharmaceuticals (MM)
03/31/200511:30AMPR Newswire (US)Genaissance Pharmaceuticals to Present at CIBC World Markets Annual Biotechnology and Specialty Pharmaceuticals ConferenceNASDAQ:GNSCGenaissance Pharmaceuticals (MM)
03/22/200512:00PMPR Newswire (US)Genaissance Comments on FDA Guidance on PharmacogenomicsNASDAQ:GNSCGenaissance Pharmaceuticals (MM)
03/11/20057:30AMPR Newswire (US)Genaissance Allowed Patent for Method of Testing Individuals for Genetic Predisposition to Reduced Metabolism of DrugsNASDAQ:GNSCGenaissance Pharmaceuticals (MM)
03/09/20058:00AMPR Newswire (US)Genaissance and Monsanto Company Team Up with the USDA to Map Soybean GenomeNASDAQ:GNSCGenaissance Pharmaceuticals (MM)
03/09/20058:00AMPR Newswire (US)Genaissance and Monsanto Company Team Up With the USDA to Map Soybean GenomeNASDAQ:GNSCGenaissance Pharmaceuticals (MM)
02/15/20057:30AMPR Newswire (US)Genaissance Pharmaceuticals' New DNA Test - FAMILION(TM) - Becoming Key Tool for Detecting Long QT Syndrome, a Potentially FatalNASDAQ:GNSCGenaissance Pharmaceuticals (MM)
02/10/20059:00AMPR Newswire (US)Genaissance Pharmaceuticals Reports 2004 ResultsNASDAQ:GNSCGenaissance Pharmaceuticals (MM)
02/03/200510:00AMPR Newswire (US)Genaissance Pharmaceuticals, Inc. Invites You to Participate in its Fourth Quarter 2004 Conference CallNASDAQ:GNSCGenaissance Pharmaceuticals (MM)
01/26/20057:30AMPR Newswire (US)Genaissance Obtains License to Vanderbilt Patent Linking Genetics to Key Drug Safety IssueNASDAQ:GNSCGenaissance Pharmaceuticals (MM)
01/24/20057:30AMPR Newswire (US)Genaissance Study Sheds Light on Mechanism of Heart Disease Risk by Linking Genetic Variation to the Effect of Hormone ReplacemeNASDAQ:GNSCGenaissance Pharmaceuticals (MM)
01/04/20057:30AMPR Newswire (US)Genaissance Allowed Patent for Novel Methods to Correlate Genetics With Drug Safety and EfficacyNASDAQ:GNSCGenaissance Pharmaceuticals (MM)
12/20/20047:30AMPR Newswire (US)Genaissance Identifies Genetic Markers Implicated in Fatal Side Effects Of Schizophrenia DrugNASDAQ:GNSCGenaissance Pharmaceuticals (MM)
12/02/20047:00AMPR Newswire (US)Genaissance Pharmaceuticals Signs Research Agreement With Sygen InternationalNASDAQ:GNSCGenaissance Pharmaceuticals (MM)
11/19/20048:56AMPR Newswire (US)Genaissance to Raise Approximately $6 Million in Private PlacementNASDAQ:GNSCGenaissance Pharmaceuticals (MM)
 Showing the most relevant articles for your search:NASDAQ:GNSC